Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Soufeng Sanjie formula is a Traditional Chinese Medicine (TCM) preparation developed by the Jiangsu Integrated Traditional Chinese and Western Medicine Hospital for the treatment of advanced rheumatoid arthritis (RA). It is specifically indicated for patients presenting with 'Phlegm-stasis bi syndrome' (痰瘀痹阻证), a TCM classification characterized by chronic joint pain, swelling, and deformity. The formula utilizes 'insecticidal' or 'wind-searching' medicinal components (chonglei yao) intended to penetrate deep into the meridians to resolve phlegm and dissipate blood stasis. Clinical research focuses on its potential to inhibit bone erosion and joint destruction, aiming to provide a scientific basis for the use of traditional insect-based drugs in managing RA progression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on soufeng sanjie formula.